These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 9426205

  • 1. Protein tyrosine kinases and cancer.
    Kolibaba KS, Druker BJ.
    Biochim Biophys Acta; 1997 Dec 09; 1333(3):F217-48. PubMed ID: 9426205
    [No Abstract] [Full Text] [Related]

  • 2. Signal transduction by wild-type and leukemogenic Abl proteins.
    Raitano AB, Whang YE, Sawyers CL.
    Biochim Biophys Acta; 1997 Dec 09; 1333(3):F201-16. PubMed ID: 9426204
    [No Abstract] [Full Text] [Related]

  • 3. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
    Ludwig L, Kessler H, Wagner M, Hoang-Vu C, Dralle H, Adler G, Böhm BO, Schmid RM.
    Cancer Res; 2001 Jun 01; 61(11):4526-35. PubMed ID: 11389085
    [Abstract] [Full Text] [Related]

  • 4. Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signalling molecules mediated by ret with the MEN 2B mutation.
    Murakami H, Iwashita T, Asai N, Shimono Y, Iwata Y, Kawai K, Takahashi M.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):68-75. PubMed ID: 10448070
    [Abstract] [Full Text] [Related]

  • 5. [Tyrosine kinase: implications in tumor pathology and therapeutic perspectives].
    Peyrade F, Taillan B, Lebrun C, Baron V, Dujardin P.
    Rev Med Interne; 1998 May 19; 19(5):366-72. PubMed ID: 9775178
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia.
    Di Fiore PP, Kraus MH.
    Cancer Treat Res; 1992 May 19; 61():139-60. PubMed ID: 1360229
    [No Abstract] [Full Text] [Related]

  • 7. A chimeric EGFR/neu receptor in studies of neu function.
    Lehtola L, Lehväslaiho H, Koskinen P, Alitalo K.
    Cancer Treat Res; 1992 May 19; 61():213-28. PubMed ID: 1360234
    [No Abstract] [Full Text] [Related]

  • 8. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines.
    Okuda K, Golub TR, Gilliland DG, Griffin JD.
    Oncogene; 1996 Sep 19; 13(6):1147-52. PubMed ID: 8808688
    [Abstract] [Full Text] [Related]

  • 9. Ret receptor tyrosine kinase activates extracellular signal-regulated kinase 2 in SK-N-MC cells.
    van Weering DH, Medema JP, van Puijenbroek A, Burgering BM, Baas PD, Bos JL.
    Oncogene; 1995 Dec 07; 11(11):2207-14. PubMed ID: 8570170
    [Abstract] [Full Text] [Related]

  • 10. A mutation in the RET proto-oncogene in Hirschsprung's disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B.
    Cosma MP, Panariello L, Quadro L, Dathan NA, Fattoruso O, Colantuoni V.
    Biochem J; 1996 Mar 01; 314 ( Pt 2)(Pt 2):397-400. PubMed ID: 8670046
    [Abstract] [Full Text] [Related]

  • 11. The role of Ets transcription factors in the development and function of the mammalian immune system.
    Bassuk AG, Leiden JM.
    Adv Immunol; 1997 Mar 01; 64():65-104. PubMed ID: 9100980
    [No Abstract] [Full Text] [Related]

  • 12. Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction.
    Kurokawa K, Iwashita T, Murakami H, Hayashi H, Kawai K, Takahashi M.
    Oncogene; 2001 Apr 12; 20(16):1929-38. PubMed ID: 11360177
    [Abstract] [Full Text] [Related]

  • 13. RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor.
    Plaza Menacho I, Koster R, van der Sloot AM, Quax WJ, Osinga J, van der Sluis T, Hollema H, Burzynski GM, Gimm O, Buys CH, Eggen BJ, Hofstra RM.
    Cancer Res; 2005 Mar 01; 65(5):1729-37. PubMed ID: 15753368
    [Abstract] [Full Text] [Related]

  • 14. [Role of the ETS transcription factors in the control of endothelial-specific gene expression and in angiogenesis].
    Lelièvre E, Lionneton F, Soncin F.
    Bull Cancer; 2001 Feb 01; 88(2):137-42. PubMed ID: 11257588
    [Abstract] [Full Text] [Related]

  • 15. [The GDNF family: from neurotrophic factors to oncogenesis].
    Poteriaev DA, Saarma M.
    Mol Biol (Mosk); 2001 Feb 01; 35(2):309-20. PubMed ID: 11357413
    [Abstract] [Full Text] [Related]

  • 16. Receptor tyrosine kinase signaling in vascular development.
    Merenmies J, Parada LF, Henkemeyer M.
    Cell Growth Differ; 1997 Jan 01; 8(1):3-10. PubMed ID: 8993829
    [No Abstract] [Full Text] [Related]

  • 17. Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.
    Salvatore D, Melillo RM, Monaco C, Visconti R, Fenzi G, Vecchio G, Fusco A, Santoro M.
    Cancer Res; 2001 Feb 15; 61(4):1426-31. PubMed ID: 11245446
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.